| Subject: | FDA Approves New Vaccine to Prevent Rotavirus Gastroenteritis in Infants |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 15 Feb 2006 - 10:00 am |
| The FDA has approved RotaTeq, a live, oral, vaccine for use in preventing rotavirus gastroenteritis in infants. It is the only vaccine approved in the United States that can help protect against rotavirus, a viral infection that may cause diarrhea, vomiting, fever, and dehydration.
In 1998, FDA approved a different live vaccine against rotavirus, RotaShield, which was later withdrawn from the market because of its association with an increased risk of intussusception. Intussusception occurs... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
REFERENCE:
Policies / Forms / Additional Resources:
|
|
StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!® Virtual Compliance Administrator™ saves you time and money. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|
